Journal
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Volume 103, Issue 4, Pages 1366-1379Publisher
WILEY
DOI: 10.1002/jbm.a.35275
Keywords
polyvinyl alcohol hydrogel; dextran; coagulation; homeostasis; vascular graft
Funding
- QREN I&DT Cluster in Development of Products for Regenerative Medicine and Cell Therapies [QREN 2008/1372]
- European Community FEDER fund through ON2 - O Novo Norte - North Portugal Regional Operational Program
- Fundacao para a Ciencia e Tecnologia (FCT), Ministerio da Educacao e da Ciencia [FCT - ENMED/0002/2010]
- program COMPETE - Programa Operacional Factores de Competitividade [OE/AGR/UI0211/2011]
- Nuno Alexandre has a Doctoral Grant from Fundacao para a Ciencia e Tecnologia (FCT), Ministerio da Educacao e da Ciencia, Portugal [SFRH/BD/64838/2009]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/64838/2009] Funding Source: FCT
Ask authors/readers for more resources
Polyvinyl alcohol hydrogel (PVA) is a water-soluble synthetic polymer that is commonly used in biomedical applications including vascular grafting. It was argued that the copolymerization of PVA with dextran (Dx) can result in improvement of blood-biomaterial interactions. The focus of this experimental study was to assess that interaction through an in vivo and in vitro evaluation of the coagulation system activation. The thrombogenicity of the copolymer was determined by quantification of platelet adhesion through the lactate dehydrogenase assay, determination of whole blood clotting time, and by quantification of platelet activation by flow cytometry. The thrombin-antithrombin complex blood levels were also determined. The obtained results for the in vitro assays suggested a non-thrombogenic profile for PVA/Dx. Additionally in vivo coagulation and hematological parameters were determined in an animal model after PVA/Dx vascular graft implantation. For coagulation homeostasis assessment, the intrinsic and extrinsic pathway's activation was determined by measuring prothrombin time (PT) and activated partial thromboplastin time (aPTT). Other markers of coagulation and inflammation activation including d-dimers, interleukin-6, and C-reactive protein were also assessed. The PVA/Dx copolymer tended to inhibit platelet adhesion/activation process and the contact activation process for coagulation. These results were also confirmed with the in vivo experiments where the measurements for APTT, interleukin-6, and C-reactive protein parameters were normal considering the species normal range of values. The response to those events is an indicator of the in vitro and in vivo hemocompatibility of PVA/Dx and it allows us to select this biomaterial for further preclinical trials in vascular reconstruction. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1366-1379, 2015.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available